Literature DB >> 23142539

Enhanced recovery from ischemia-reperfusion injury in PI3Kα dominant negative hearts: investigating the role of alternate PI3K isoforms, increased glucose oxidation and MAPK signaling.

Brent A McLean1, Petra C Kienesberger, Wang Wang, Grant Masson, Pavel Zhabyeyev, Jason R B Dyck, Gavin Y Oudit.   

Abstract

Classical ischemia-reperfusion (IR) preconditioning relies on phosphatidylinositol 3-kinase (PI3K) for protective signaling. Surprisingly, inhibition of PI3Kα activity using a dominant negative (DN) strategy protected the murine heart from IR injury. It has been proposed that increased signaling through PI3Kγ may contribute to the improved recovery of PI3KαDN hearts following IR. To investigate the mechanism by which PI3KαDN hearts are protected from IR injury, we created a double mutant (PI3KDM) model by crossing p110γ(-/-) (PI3KγKO) with cardiac-specific PI3KαDN mice. The PI3KDM model has morphological and hemodynamic features that are characteristic of both PI3Kγ(-/-) and PI3KαDN mice. Interestingly, when subjected to IR using ex vivo Langendorff perfusion, PI3KDM hearts showed significantly enhanced functional recovery when compared to wildtype (WT) hearts. However, signaling downstream of PI3K through Akt and GSK3β, which has been associated with IR protection, was reduced in PI3KDM hearts. Using ex vivo working heart perfusion, we found no difference in functional recovery after IR between PI3KDM and PI3KαDN; also, glucose oxidation rates were significantly increased in PI3KαDN hearts when compared to WT, and this metabolic shift has been associated with enhanced IR recovery. However, we found that PI3KαDN hearts still had enhanced recovery when perfused exclusively with fatty acids (FA). We then investigated parallel signaling pathways, and found that mitogen-activated protein kinase signaling was increased in PI3KαDN hearts, possibly through the inhibition of negative feedback loops downstream of PI3Kα.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142539     DOI: 10.1016/j.yjmcc.2012.10.015

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Changes in the loading conditions induced by vagal stimulation modify the myocardial infarct size through sympathetic-parasympathetic interactions.

Authors:  Bruno Buchholz; Martín Donato; Virginia Perez; Ana Clara Rey Deutsch; Christian Höcht; Julieta S Del Mauro; Manuel Rodríguez; Ricardo J Gelpi
Journal:  Pflugers Arch       Date:  2014-08-17       Impact factor: 3.657

Review 2.  Mammalian target of rapamycin signaling in cardiac physiology and disease.

Authors:  Sebastiano Sciarretta; Massimo Volpe; Junichi Sadoshima
Journal:  Circ Res       Date:  2014-01-31       Impact factor: 17.367

3.  Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning.

Authors:  Qiming Duan; Namrata D Madan; Jian Wu; Jennifer Kalisz; Krunal Y Doshi; Saptarsi M Haldar; Lijun Liu; Sandrine V Pierre
Journal:  J Mol Cell Cardiol       Date:  2015-01-07       Impact factor: 5.000

4.  Vascular endothelial growth factor-B: Impact on physiology and pathology.

Authors:  Hongyu Zhu; Mingming Gao; Xiangdong Gao; Yue Tong
Journal:  Cell Adh Migr       Date:  2017-11-02       Impact factor: 3.405

5.  VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.

Authors:  Riikka Kivelä; Maija Bry; Marius R Robciuc; Markus Räsänen; Miia Taavitsainen; Johanna M U Silvola; Antti Saraste; Juha J Hulmi; Andrey Anisimov; Mikko I Mäyränpää; Jan H Lindeman; Lauri Eklund; Sanna Hellberg; Ruslan Hlushchuk; Zhen W Zhuang; Michael Simons; Valentin Djonov; Juhani Knuuti; Eero Mervaala; Kari Alitalo
Journal:  EMBO Mol Med       Date:  2014-01-21       Impact factor: 12.137

6.  Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury.

Authors:  Guo-Hua Li; Bin Luo; Yan-Xia Lv; Fei Zheng; Lu Wang; Meng-Xi Wei; Xian-Yu Li; Lei Zhang; Jia-Ning Wang; Shi-You Chen; Jun-Ming Tang; Xiaohua He
Journal:  J Transl Med       Date:  2016-05-04       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.